Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • ECCO

Tag: ECCO

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
Posted in Business

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Estimated read time 14 min read
Posted on February 22, 2025
by Joelgalvan

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…

Learn More Leave a Comment on Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Recent Posts

  • What Is Image to Image?
  • Pieter Coetze stuns swimming elite, upsets Olympic champ Thomas Ceccon in thrilling race at World Championships after double gold at University Games
  • Gasoline prices to fall to 18-month low Thursday night
  • AIG Women’s Open: Charley Hull opens up on major hopes, Lottie Woad’s rise, links golf struggles and fitness issues | Golf News
  • Roblox x Parsons School [Trend Report]

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.